Indeed, increasing the PPP flux via G6PD stimulation has been found to trigger cancer progression in a variety of tumor types [29–31], coordinate tumor cell cycle progression [32, 33], promote antioxidant defense and metastasis [8, 34], and increase drug resistance [35, 36]. Here, G6PD is linked to cancer.